Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended

Author:

Faselis Charles123,Nations Joel A.13,Morgan Charity J.14,Antevil Jared13,Roseman Jeffrey M.5,Zhang Sijian1,Fonarow Gregg C.6,Sheriff Helen M.12,Trachiotis Gregory D.178,Allman Richard M.29,Deedwania Prakash110,Zeng-Trietler Qing12,Taub Daniel D.1,Ahmed Amiya A.11,Howard George4,Ahmed Ali1212

Affiliation:

1. Veterans Affairs Medical Center, Washington, DC

2. Department of Medicine, School of Medicine, George Washington University, Washington, DC

3. Department of Medicine, School of Medicine, Uniformed Services University, Washington, DC

4. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham

5. Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham

6. Department of Medicine, School of Medicine, University of California, Los Angeles, Los Angeles

7. Department of Surgery, School of Medicine, George Washington University, Washington, DC

8. Department of Biomedical Engineering, School of Engineering and Applied Science, George Washington University, Washington, DC

9. Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham

10. Department of Medicine, School of Medicine, University of California, San Francisco, San Francisco

11. Department of Medicine, School of Medicine, Yale University, New Haven, Connecticut

12. Department of Medicine, School of Medicine, Georgetown University, Washington, DC

Abstract

ImportanceThe US Preventive Services Task Force does not recommend annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who are former smokers with 20 or more pack-years of smoking who quit 15 or more years ago or current smokers with less than 20 pack-years of smoking.ObjectiveTo determine the risk of lung cancer in older smokers for whom LDCT screening is not recommended.Design, Settings, and ParticipantsThis cohort study used the Cardiovascular Health Study (CHS) data sets obtained from the National Heart, Lung and Blood Institute, which also sponsored the study. The CHS enrolled 5888 community-dwelling individuals aged 65 years and older in the US from June 1989 to June 1993 and collected extensive baseline data on smoking history. The current analysis was restricted to 4279 individuals free of cancer who had baseline data on pack-year smoking history and duration of smoking cessation. The current analysis was conducted from January 7, 2022, to May 25, 2022.ExposuresCurrent and prior tobacco use.Main Outcomes and MeasuresIncident lung cancer during a median (IQR) of 13.3 (7.9-18.8) years of follow-up (range, 0 to 22.6) through December 31, 2011. A Fine-Gray subdistribution hazard model was used to estimate incidence of lung cancer in the presence of competing risk of death. Cox cause-specific hazard regression models were used to estimate hazard ratios (HRs) and 95% CIs for incident lung cancer.ResultsThere were 4279 CHS participants (mean [SD] age, 72.8 [5.6] years; 2450 [57.3%] women; 663 [15.5%] African American, 3585 [83.8%] White, and 31 [0.7%] of other race or ethnicity) included in the current analysis. Among the 861 nonheavy smokers (<20 pack-years), the median (IQR) pack-year smoking history was 7.6 (3.3-13.5) pack-years for the 615 former smokers with 15 or more years of smoking cessation, 10.0 (5.3-14.9) pack-years for the 146 former smokers with less than 15 years of smoking cessation, and 11.4 (7.3-14.4) pack-years for the 100 current smokers. Among the 1445 heavy smokers (20 or more pack-years), the median (IQR) pack-year smoking history was 34.8 (26.3-48.0) pack-years for the 516 former smokers with 15 or more years of smoking cessation, 48.0 (35.0-70.0) pack-years for the 497 former smokers with less than 15 years of smoking cessation, and 48.8 (31.6-57.0) pack-years for the 432 current smokers. Incident lung cancer occurred in 10 of 1973 never smokers (0.5%), 5 of 100 current smokers with less than 20 pack-years of smoking (5.0%), and 26 of 516 former smokers with 20 or more pack-years of smoking with 15 or more years of smoking cessation (5.0%). Compared with never smokers, cause-specific HRs for incident lung cancer in the 2 groups for whom LDCT is not recommended were 10.54 (95% CI, 3.60-30.83) for the current nonheavy smokers and 11.19 (95% CI, 5.40-23.21) for the former smokers with 15 or more years of smoking cessation; age, sex, and race–adjusted HRs were 10.06 (95% CI, 3.41-29.70) for the current nonheavy smokers and 10.22 (4.86-21.50) for the former smokers with 15 or more years of smoking cessation compared with never smokers.Conclusions and RelevanceThe findings of this cohort study suggest that there is a high risk of lung cancer among smokers for whom LDCT screening is not recommended, suggesting that prediction models are needed to identify high-risk subsets of these smokers for screening.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference35 articles.

1. Lung cancer incidence trends among men and women–United States, 2005-2009.;Henley;MMWR Morb Mortal Wkly Rep,2014

2. Reduced lung-cancer mortality with low-dose computed tomographic screening.;Aberle;N Engl J Med,2011

3. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.;de Koning;N Engl J Med,2020

4. Screening for lung cancer: US Preventive Services Task Force recommendation statement.;Krist;JAMA,2021

5. The cardiovascular health study: Design and rationale

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3